Accordingly, 60–70% of tumor cells expressed CXCR7 (α6-integrin+/CXCR7+ cells) in WD-SCCs and this frequency was not significantly increased in PD/S-SCCs (Fig. 1e, f). This evidence concerns the gene ACKR3 and Wilson disease.